APO Research
Talk to an analyst

APO RESEARCH · REPORT

Lipid Nanoparticle (LNP) Formulation

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Lipid Nanoparticle (LNP) Formulation Industry Growth and Trends Forecast to 2032

5 June 202685 pages

Choose your research edition.

Industry ResearchLipid Nanoparticle (LNP) Formulation Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Lipid Nanoparticle (LNP) Formulation Industry Growth and Trends Forecast to 203285 pages · $3,450 USDMarket StructureGlobal Lipid Nanoparticle (LNP) Formulation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032189 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Lipid Nanoparticle (LNP) Formulation Market Outlook and Growth Opportunities 2026191 pages · $4,250 USDMarket Analysis & ForecastGlobal Lipid Nanoparticle (LNP) Formulation Market Analysis and Forecast 2026-2032189 pages · $4,950 USD

Market perspective

According to APO Research, the global Lipid Nanoparticle (LNP) Formulation market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Lipid Nanoparticle (LNP) Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Lipid Nanoparticle (LNP) Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Lipid Nanoparticle (LNP) Formulation is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global companies in the Lipid Nanoparticle (LNP) Formulation market include Precision NanoSystems (Cytiva), Ascendia Pharmaceuticals, CordenPharma, Evonik, Merck Millipore, Esco Aster, WuXi STA and Helix Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Lipid Nanoparticle (LNP) Formulation market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Lipid Nanoparticle (LNP) Formulation market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Lipid Nanoparticle (LNP) Formulation market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Lipid Nanoparticle (LNP) Formulation.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading companies in the global Lipid Nanoparticle (LNP) Formulation market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Lipid Nanoparticle (LNP) Formulation Market by Company

Precision NanoSystems (Cytiva)

Ascendia Pharmaceuticals

CordenPharma

Evonik

Merck Millipore

Esco Aster

WuXi STA

Helix Biotech

Lipid Nanoparticle (LNP) Formulation Segment by Type

mRNA-lipid Nanoparticle

siRNA-lipid Nanoparticle

Lipid Nanoparticle (LNP) Formulation Segment by Application

In Vitro and In Vivo Diagnostics

Medical Imaging

Nanotherapeutics

Vaccines

Regenerative Medicine

Lipid Nanoparticle (LNP) Formulation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Lipid Nanoparticle (LNP) Formulation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Lipid Nanoparticle (LNP) Formulation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market

5. This report helps stakeholders to gain insights into which regions to target globally

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Lipid Nanoparticle (LNP) Formulation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 5: Detailed analysis of Lipid Nanoparticle (LNP) Formulation companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.

Chapter 12: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Global Lipid Nanoparticle (LNP) Formulation Market Size (US$ Million) Comparison by Region: 2021 VS 2025 VS 2032 Table 2. Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2021-2026) & (US$ Million) Table 3. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region (2021-2026) Table 4. Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2027-2032) & (US$ Million) Table 5. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region (2027-2032) Table 6. Global Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 7. Global Lipid Nanoparticle (LNP) Formulation Market Size by Type (2021-2026) & (US$ Million) Table 8. Global Lipid Nanoparticle (LNP) Formulation Market Size Share by Type (2021-2026) Table 9. Global Lipid Nanoparticle (LNP) Formulation Market Size Forecasted by Type (2027-2032) & (US$ Million) Table 10. Global Lipid Nanoparticle (LNP) Formulation Market Size Share Forecasted by Type (2027-2032) Table 11. North America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 12. North America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 13. Europe Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 14. Europe Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 15. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 16. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 17. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 18. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 19. Middle East and Africa Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026) & (US$ Million) Table 20. Middle East and Africa Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2027-2032) & (US$ Million) Table 21. Global Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 22. Global Lipid Nanoparticle (LNP) Formulation Market Size by Application (2021-2026) & (US$ Million) Table 23. Global Lipid Nanoparticle (LNP) Formulation Market Size Share by Application (2021-2026) Table 24. Global Lipid Nanoparticle (LNP) Formulation Market Size Forecasted by Application (2027-2032) & (US$ Million) Table 25. Global Lipid Nanoparticle (LNP) Formulation Market Size Share Forecasted by Application (2027-2032) Table 26. North America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 27. North America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 28. Europe Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 29. Europe Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 30. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 31. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 32. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 33. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 34. Middle East and Africa Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026) & (US$ Million) Table 35. Middle East and Africa Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2027-2032) & (US$ Million) Table 36. Lipid Nanoparticle (LNP) Formulation Industry Trends Table 37. Lipid Nanoparticle (LNP) Formulation Industry Drivers Table 38. Lipid Nanoparticle (LNP) Formulation Industry Opportunities and Challenges Table 39. Lipid Nanoparticle (LNP) Formulation Industry Restraints Table 40. Global Lipid Nanoparticle (LNP) Formulation Revenue by Company (US$ Million) & (2021-2026) Table 41. Global Lipid Nanoparticle (LNP) Formulation Revenue Market Share by Company (2021-2026) Table 42. Global Lipid Nanoparticle (LNP) Formulation Industry Company Ranking, 2024 VS 2025 VS 2026 Table 43. Global Lipid Nanoparticle (LNP) Formulation Key Company Headquarters & Area Served Table 44. Global Lipid Nanoparticle (LNP) Formulation Company, Product Type & Application Table 45. Global Lipid Nanoparticle (LNP) Formulation Company Commercialization Time Table 46. Global Company Market Concentration Ratio (CR5 and HHI) Table 47. Global Lipid Nanoparticle (LNP) Formulation by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 48. Precision NanoSystems (Cytiva) Company Information Table 49. Precision NanoSystems (Cytiva) Business Overview Table 50. Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 51. Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 52. Precision NanoSystems (Cytiva) Recent Development Table 53. Ascendia Pharmaceuticals Company Information Table 54. Ascendia Pharmaceuticals Business Overview Table 55. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 56. Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 57. Ascendia Pharmaceuticals Recent Development Table 58. CordenPharma Company Information Table 59. CordenPharma Business Overview Table 60. CordenPharma Lipid Nanoparticle (LNP) Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 61. CordenPharma Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 62. CordenPharma Recent Development Table 63. Evonik Company Information Table 64. Evonik Business Overview Table 65. Evonik Lipid Nanoparticle (LNP) Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 66. Evonik Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 67. Evonik Recent Development Table 68. Merck Millipore Company Information Table 69. Merck Millipore Business Overview Table 70. Merck Millipore Lipid Nanoparticle (LNP) Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 71. Merck Millipore Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 72. Merck Millipore Recent Development Table 73. Esco Aster Company Information Table 74. Esco Aster Business Overview Table 75. Esco Aster Lipid Nanoparticle (LNP) Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 76. Esco Aster Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 77. Esco Aster Recent Development Table 78. WuXi STA Company Information Table 79. WuXi STA Business Overview Table 80. WuXi STA Lipid Nanoparticle (LNP) Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 81. WuXi STA Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 82. WuXi STA Recent Development Table 83. Helix Biotech Company Information Table 84. Helix Biotech Business Overview Table 85. Helix Biotech Lipid Nanoparticle (LNP) Formulation Revenue (US$ Million), Global Share (%) and Gross Margin (2021-2026) Table 86. Helix Biotech Lipid Nanoparticle (LNP) Formulation Product Portfolio Table 87. Helix Biotech Recent Development Table 88. North America Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 89. North America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) & (US$ Million) Table 90. North America Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2026) Table 91. North America Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 92. North America Lipid Nanoparticle (LNP) Formulation Market Share Forecast by Country (2027-2032) Table 93. Europe Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 94. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) & (US$ Million) Table 95. Europe Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2026) Table 96. Europe Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 97. Europe Lipid Nanoparticle (LNP) Formulation Market Share Forecast by Country (2027-2032) Table 98. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 99. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) & (US$ Million) Table 100. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2026) Table 101. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 102. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Share Forecast by Country (2027-2032) Table 103. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 104. Latin America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) & (US$ Million) Table 105. Latin America Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2026) Table 106. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 107. Latin America Lipid Nanoparticle (LNP) Formulation Market Share Forecast by Country (2027-2032) Table 108. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 109. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026) & (US$ Million) Table 110. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2026) Table 111. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032) & (US$ Million) Table 112. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share Forecast by Country (2027-2032) Table 113. Research Programs/Design for This Report Table 114. Authors List of This Report Table 115. Secondary Sources List of Figures Figure 1.List of Figures Figure 2. Lipid Nanoparticle (LNP) Formulation Product Image Figure 3. Global Lipid Nanoparticle (LNP) Formulation Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 4. Global Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032) & (US$ Million) Figure 5. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region: 2025 VS 2032 Figure 6. Global Lipid Nanoparticle (LNP) Formulation Market Share by Region (2021-2032) Figure 7. North America Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 8. Europe Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 9. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 10. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 11. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032) & (US$ Million) Figure 12. mRNA-lipid Nanoparticle Image Figure 13. Global mRNA-lipid Nanoparticle Market Size YoY Growth (2021-2032) & (US$ Million) Figure 14. siRNA-lipid Nanoparticle Image Figure 15. Global siRNA-lipid Nanoparticle Market Size YoY Growth (2021-2032) & (US$ Million) Figure 16. Global Lipid Nanoparticle (LNP) Formulation Market Size Overview by Type (2021-2032) & (US$ Million) Figure 17. Global Lipid Nanoparticle (LNP) Formulation Market Share by Type 2025 VS 2032 Figure 18. North America Lipid Nanoparticle (LNP) Formulation Market Size Share by Type (2021-2032) Figure 19. Europe Lipid Nanoparticle (LNP) Formulation Market Size Share by Type (2021-2032) Figure 20. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Share by Type (2021-2032) Figure 21. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Share by Type (2021-2032) Figure 22. Middle East and Africa Lipid Nanoparticle (LNP) Formulation Market Size Share by Type (2021-2032) Figure 23. In Vitro and In Vivo Diagnostics Image Figure 24. Global In Vitro and In Vivo Diagnostics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 25. Medical Imaging Image Figure 26. Global Medical Imaging Market Size YoY Growth (2021-2032) & (US$ Million) Figure 27. Nanotherapeutics Image Figure 28. Global Nanotherapeutics Market Size YoY Growth (2021-2032) & (US$ Million) Figure 29. Vaccines Image Figure 30. Global Vaccines Market Size YoY Growth (2021-2032) & (US$ Million) Figure 31. Regenerative Medicine Image Figure 32. Global Regenerative Medicine Market Size YoY Growth (2021-2032) & (US$ Million) Figure 33. Global Lipid Nanoparticle (LNP) Formulation Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Lipid Nanoparticle (LNP) Formulation Market Share by Application 2025 VS 2032 Figure 35. North America Lipid Nanoparticle (LNP) Formulation Market Size Share by Application (2021-2032) Figure 36. Europe Lipid Nanoparticle (LNP) Formulation Market Size Share by Application (2021-2032) Figure 37. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Share by Application (2021-2032) Figure 38. Latin America Lipid Nanoparticle (LNP) Formulation Market Size Share by Application (2021-2032) Figure 39. Middle East and Africa Lipid Nanoparticle (LNP) Formulation Market Size Share by Application (2021-2032) Figure 40. Global Top 5 and 10 Lipid Nanoparticle (LNP) Formulation Players Market Share by Revenue in 2025 Figure 41. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 42. North America Lipid Nanoparticle (LNP) Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 43. North America Lipid Nanoparticle (LNP) Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 44. North America Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 45. Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 46. Europe Lipid Nanoparticle (LNP) Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 47. Europe Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 48. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 49. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 50. Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 51. Latin America Lipid Nanoparticle (LNP) Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Latin America Lipid Nanoparticle (LNP) Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Latin America Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 54. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 55. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Country: 2021 VS 2025 VS 2032 Figure 56. Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Share by Country (2021-2032) Figure 57. Years Considered Figure 58. Research Process Figure 59. Key Executives Interviewed

Scope & coverage.

Types
  • mRNA-lipid Nanoparticle
  • siRNA-lipid Nanoparticle
Applications
  • In Vitro and In Vivo Diagnostics
  • Medical Imaging
  • Nanotherapeutics
  • Vaccines
  • Regenerative Medicine
Companies covered
  • Precision NanoSystems (Cytiva)
  • Ascendia Pharmaceuticals
  • CordenPharma
  • Evonik
  • Merck Millipore
  • Esco Aster
  • WuXi STA
  • Helix Biotech

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.3 Global Lipid Nanoparticle (LNP) Formulation Market Size Overview by Region 2021 VS 2025 VS 2032
  4. 1.4 Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2021-2032)
  5. 1.4.1 Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2021-2026)
  6. 1.4.2 Global Lipid Nanoparticle (LNP) Formulation Market Size by Region (2027-2032)
  7. 1.5 Key Regions Lipid Nanoparticle (LNP) Formulation Market Size (2021-2032)
  8. 1.5.1 North America Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032)
  9. 1.5.2 Europe Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032)
  10. 1.5.3 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032)
  11. 1.5.4 South America Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032)
  12. 1.5.5 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (2021-2032)
2 Lipid Nanoparticle (LNP) Formulation Market by Type
  1. 2.1 Type Introduction
  2. 2.1.1 mRNA-lipid Nanoparticle
  3. 2.1.2 siRNA-lipid Nanoparticle
  4. 2.2 Global Lipid Nanoparticle (LNP) Formulation Market Size by Type
  5. 2.2.1 Global Lipid Nanoparticle (LNP) Formulation Market Size Overview by Type (2021-2032)
  6. 2.2.2 Global Lipid Nanoparticle (LNP) Formulation Historic Market Size Review by Type (2021-2026)
  7. 2.2.3 Global Lipid Nanoparticle (LNP) Formulation Market Size Forecasted by Type (2027-2032)
  8. 2.3 Global Lipid Nanoparticle (LNP) Formulation Market Size by Regions
  9. 2.3.1 North America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026)
  10. 2.3.2 Europe Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026)
  11. 2.3.3 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026)
  12. 2.3.4 South America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026)
  13. 2.3.5 Middle East and Africa Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Type (2021-2026)
3 Lipid Nanoparticle (LNP) Formulation Market by Application
  1. 3.1 Type Introduction
  2. 3.1.1 In Vitro and In Vivo Diagnostics
  3. 3.1.2 Medical Imaging
  4. 3.1.3 Nanotherapeutics
  5. 3.1.4 Vaccines
  6. 3.1.5 Regenerative Medicine
  7. 3.2 Global Lipid Nanoparticle (LNP) Formulation Market Size by Application
  8. 3.2.1 Global Lipid Nanoparticle (LNP) Formulation Market Size Overview by Application (2021-2032)
  9. 3.2.2 Global Lipid Nanoparticle (LNP) Formulation Historic Market Size Review by Application (2021-2026)
  10. 3.2.3 Global Lipid Nanoparticle (LNP) Formulation Market Size Forecasted by Application (2027-2032)
  11. 3.3 Global Lipid Nanoparticle (LNP) Formulation Market Size by Regions
  12. 3.3.1 North America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026)
  13. 3.3.2 Europe Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026)
  14. 3.3.3 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026)
  15. 3.3.4 South America Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026)
  16. 3.3.5 Middle East and Africa Lipid Nanoparticle (LNP) Formulation Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
  1. 4.1 Lipid Nanoparticle (LNP) Formulation Industry Trends
  2. 4.2 Lipid Nanoparticle (LNP) Formulation Industry Drivers
  3. 4.3 Lipid Nanoparticle (LNP) Formulation Industry Opportunities and Challenges
  4. 4.4 Lipid Nanoparticle (LNP) Formulation Industry Restraints
5 Competitive Insights by Company
  1. 5.1 Global Top Players by Lipid Nanoparticle (LNP) Formulation Revenue (2021-2026)
  2. 5.2 Global Lipid Nanoparticle (LNP) Formulation Industry Company Ranking, 2024 VS 2025 VS 2026
  3. 5.3 Global Lipid Nanoparticle (LNP) Formulation Key Company Headquarters & Area Served
  4. 5.4 Global Lipid Nanoparticle (LNP) Formulation Company, Product Type & Application
  5. 5.5 Global Lipid Nanoparticle (LNP) Formulation Company Commercialization Time
  6. 5.6 Market Competitive Analysis
  7. 5.6.1 Global Lipid Nanoparticle (LNP) Formulation Market CR5 and HHI
  8. 5.6.2 Global Top 5 and 10 Lipid Nanoparticle (LNP) Formulation Players Market Share by Revenue in 2025
  9. 5.6.3 2025 Lipid Nanoparticle (LNP) Formulation Tier 1, Tier 2, and Tier 3
6 Company Profiles
  1. 6.1 Precision NanoSystems (Cytiva)
  2. 6.1.1 Precision NanoSystems (Cytiva) Company Information
  3. 6.1.2 Precision NanoSystems (Cytiva) Business Overview
  4. 6.1.3 Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Revenue, Global Share and Gross Margin (2021-2026)
  5. 6.1.4 Precision NanoSystems (Cytiva) Lipid Nanoparticle (LNP) Formulation Product Portfolio
  6. 6.1.5 Precision NanoSystems (Cytiva) Recent Developments
  7. 6.2 Ascendia Pharmaceuticals
  8. 6.2.1 Ascendia Pharmaceuticals Company Information
  9. 6.2.2 Ascendia Pharmaceuticals Business Overview
  10. 6.2.3 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Revenue, Global Share and Gross Margin (2021-2026)
  11. 6.2.4 Ascendia Pharmaceuticals Lipid Nanoparticle (LNP) Formulation Product Portfolio
  12. 6.2.5 Ascendia Pharmaceuticals Recent Developments
  13. 6.3 CordenPharma
  14. 6.3.1 CordenPharma Company Information
  15. 6.3.2 CordenPharma Business Overview
  16. 6.3.3 CordenPharma Lipid Nanoparticle (LNP) Formulation Revenue, Global Share and Gross Margin (2021-2026)
  17. 6.3.4 CordenPharma Lipid Nanoparticle (LNP) Formulation Product Portfolio
  18. 6.3.5 CordenPharma Recent Developments
  19. 6.4 Evonik
  20. 6.4.1 Evonik Company Information
  21. 6.4.2 Evonik Business Overview
  22. 6.4.3 Evonik Lipid Nanoparticle (LNP) Formulation Revenue, Global Share and Gross Margin (2021-2026)
  23. 6.4.4 Evonik Lipid Nanoparticle (LNP) Formulation Product Portfolio
  24. 6.4.5 Evonik Recent Developments
  25. 6.5 Merck Millipore
  26. 6.5.1 Merck Millipore Company Information
  27. 6.5.2 Merck Millipore Business Overview
  28. 6.5.3 Merck Millipore Lipid Nanoparticle (LNP) Formulation Revenue, Global Share and Gross Margin (2021-2026)
  29. 6.5.4 Merck Millipore Lipid Nanoparticle (LNP) Formulation Product Portfolio
  30. 6.5.5 Merck Millipore Recent Developments
  31. 6.6 Esco Aster
  32. 6.6.1 Esco Aster Company Information
  33. 6.6.2 Esco Aster Business Overview
  34. 6.6.3 Esco Aster Lipid Nanoparticle (LNP) Formulation Revenue, Global Share and Gross Margin (2021-2026)
  35. 6.6.4 Esco Aster Lipid Nanoparticle (LNP) Formulation Product Portfolio
  36. 6.6.5 Esco Aster Recent Developments
  37. 6.7 WuXi STA
  38. 6.7.1 WuXi STA Company Information
  39. 6.7.2 WuXi STA Business Overview
  40. 6.7.3 WuXi STA Lipid Nanoparticle (LNP) Formulation Revenue, Global Share and Gross Margin (2021-2026)
  41. 6.7.4 WuXi STA Lipid Nanoparticle (LNP) Formulation Product Portfolio
  42. 6.7.5 WuXi STA Recent Developments
  43. 6.8 Helix Biotech
  44. 6.8.1 Helix Biotech Company Information
  45. 6.8.2 Helix Biotech Business Overview
  46. 6.8.3 Helix Biotech Lipid Nanoparticle (LNP) Formulation Revenue, Global Share and Gross Margin (2021-2026)
  47. 6.8.4 Helix Biotech Lipid Nanoparticle (LNP) Formulation Product Portfolio
  48. 6.8.5 Helix Biotech Recent Developments
7 North America
  1. 7.1 North America Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 7.2 North America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  3. 7.3 North America Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032)
8 Europe
  1. 8.1 Europe Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 8.2 Europe Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  3. 8.3 Europe Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
  1. 9.1 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 9.2 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  3. 9.3 Asia-Pacific Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032)
10 South America
  1. 10.1 South America Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 10.2 South America Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  3. 10.3 South America Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
  1. 11.1 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  2. 11.2 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size by Country (2021-2026)
  3. 11.3 Middle East & Africa Lipid Nanoparticle (LNP) Formulation Market Size Forecast by Country (2027-2032)
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst